Cullinan Therapeutics (CGEM) Change in Acquisitions & Divestments: 2020-2023
Historic Change in Acquisitions & Divestments for Cullinan Therapeutics (CGEM) over the last 4 years, with Dec 2023 value amounting to $117.5 million.
- Cullinan Therapeutics' Change in Acquisitions & Divestments fell 11.40% to $117.5 million in Q4 2023 from the same period last year, while for Dec 2023 it was $409.4 million, marking a year-over-year increase of 16.00%. This contributed to the annual value of $584.8 million for FY2024, which is 42.85% up from last year.
- According to the latest figures from Q4 2023, Cullinan Therapeutics' Change in Acquisitions & Divestments is $117.5 million, which was up 25.22% from $93.8 million recorded in Q3 2023.
- In the past 5 years, Cullinan Therapeutics' Change in Acquisitions & Divestments ranged from a high of $132.6 million in Q4 2022 and a low of $4.2 million during Q1 2020.
- Moreover, its 3-year median value for Change in Acquisitions & Divestments was $79.5 million (2022), whereas its average is $79.5 million.
- In the last 5 years, Cullinan Therapeutics' Change in Acquisitions & Divestments skyrocketed by 662.08% in 2022 and then dropped by 11.40% in 2023.
- Quarterly analysis of 4 years shows Cullinan Therapeutics' Change in Acquisitions & Divestments stood at $32.9 million in 2020, then skyrocketed by 86.41% to $61.4 million in 2021, then surged by 115.96% to $132.6 million in 2022, then dropped by 11.40% to $117.5 million in 2023.
- Its Change in Acquisitions & Divestments was $117.5 million in Q4 2023, compared to $93.8 million in Q3 2023 and $93.6 million in Q2 2023.